These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 24938435

  • 21. Application of Sparse Linear Discriminant Analysis and Elastic Net for Diagnosis of IgA Nephropathy: Statistical and Biological Viewpoints.
    Mohammadi Majd T, Kalantari S, Raeisi Shahraki H, Nafar M, Almasi A, Samavat S, Parvin M, Hashemian A.
    Iran Biomed J; 2018 Nov; 22(6):374-84. PubMed ID: 29523019
    [Abstract] [Full Text] [Related]

  • 22. A fast and efficient liquid chromatography-tandem mass spectrometry method for measuring l- and d-amino acids in the urine of patients with immunoglobulin A nephropathy.
    Zha Z, Wang R, Wang Q, Chen F, Ye Z, Li Y.
    Biomed Chromatogr; 2024 Jun; 38(6):e5866. PubMed ID: 38618866
    [Abstract] [Full Text] [Related]

  • 23. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
    Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X.
    Rapid Commun Mass Spectrom; 2010 Jul 30; 24(14):1971-8. PubMed ID: 20552702
    [Abstract] [Full Text] [Related]

  • 24. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J.
    Nephrol Dial Transplant; 2006 Sep 30; 21(9):2478-84. PubMed ID: 16757497
    [Abstract] [Full Text] [Related]

  • 25. Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.
    He Q, Shao L, Yu J, Ji S, Wang H, Mao Y, Chen J.
    J Biomed Nanotechnol; 2012 Feb 30; 8(1):133-9. PubMed ID: 22515101
    [Abstract] [Full Text] [Related]

  • 26. Urinary proteome profiling using microfluidic technology on a chip.
    Thongboonkerd V, Songtawee N, Sritippayawan S.
    J Proteome Res; 2007 May 30; 6(5):2011-8. PubMed ID: 17429990
    [Abstract] [Full Text] [Related]

  • 27. Urine proteomics for prediction of disease progression in patients with IgA nephropathy.
    Rudnicki M, Siwy J, Wendt R, Lipphardt M, Koziolek MJ, Maixnerova D, Peters B, Kerschbaum J, Leierer J, Neprasova M, Banasik M, Sanz AB, Perez-Gomez MV, Ortiz A, Stegmayr B, Tesar V, Mischak H, Beige J, Reich HN, PERSTIGAN working group.
    Nephrol Dial Transplant; 2021 Dec 31; 37(1):42-52. PubMed ID: 33313853
    [Abstract] [Full Text] [Related]

  • 28. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
    Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, Zürbig P, Schiffer E, Haubitz M, Moldoveanu Z, Calcatera SM, Wyatt RJ, Sýkora J, Sládková E, Hes O, Mischak H, McGuire BM.
    Electrophoresis; 2007 Dec 31; 28(23):4469-83. PubMed ID: 18004714
    [Abstract] [Full Text] [Related]

  • 29. Comparative proteomic analysis of urine and laser microdissected glomeruli in IgA nephropathy.
    Ning X, Yin Z, Li Z, Xu J, Wang L, Shen W, Lu Y, Cai G, Zhang X, Chen X.
    Clin Exp Pharmacol Physiol; 2017 May 31; 44(5):576-585. PubMed ID: 28109170
    [Abstract] [Full Text] [Related]

  • 30. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography.
    Kalantari S, Rutishauser D, Samavat S, Nafar M, Mahmudieh L, Rezaei-Tavirani M, Zubarev RA.
    PLoS One; 2013 May 31; 8(12):e80830. PubMed ID: 24339887
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
    Jiang WL, Peng YM, Liu YH, Liu H, Chen GC, Xu XQ, Zhu XJ, Liu FY.
    Ren Fail; 2012 May 31; 34(7):821-6. PubMed ID: 22679920
    [Abstract] [Full Text] [Related]

  • 32. [Urinary fibronectin excretion as a marker of disease activity in children with IgA nephropathy and Henoch-Schönlein nephropathy].
    Roszkowska-Blaim M, Mizerska-Wasiak M, Bartłomiejczyk I.
    Przegl Lek; 2006 May 31; 63 Suppl 3():90-3. PubMed ID: 16898499
    [Abstract] [Full Text] [Related]

  • 33. Vitamin D-Binding Protein Is a Potential Urinary Biomarker of Irbesartan Treatment Response in Patients with IgA Nephropathy.
    Zeng J, Wen Q, Rong R, Huang F, Yang Q, Tang X, He F, Huang N, Yu X.
    Genet Test Mol Biomarkers; 2016 Nov 31; 20(11):666-673. PubMed ID: 27603418
    [Abstract] [Full Text] [Related]

  • 34. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 35. Characterization of glomerular extracellular matrix in IgA nephropathy by proteomic analysis of laser-captured microdissected glomeruli.
    Paunas FTI, Finne K, Leh S, Osman TA, Marti HP, Berven F, Vikse BE.
    BMC Nephrol; 2019 Nov 14; 20(1):410. PubMed ID: 31726998
    [Abstract] [Full Text] [Related]

  • 36. Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression.
    Xia YY, Bu R, Cai GY, Zhang XG, Duan SW, Wu J, Wu D, Chen XM.
    BMC Nephrol; 2019 Apr 03; 20(1):118. PubMed ID: 30943905
    [Abstract] [Full Text] [Related]

  • 37. Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria.
    Yokota H, Hiramoto M, Okada H, Kanno Y, Yuri M, Morita S, Naitou M, Ichikawa A, Katoh M, Suzuki H.
    Mol Cell Proteomics; 2007 Apr 03; 6(4):738-44. PubMed ID: 17242005
    [Abstract] [Full Text] [Related]

  • 38. Volatile Organic Metabolites Identify Patients with Mesangial Proliferative Glomerulonephritis, IgA Nephropathy and Normal Controls.
    Wang C, Feng Y, Wang M, Pi X, Tong H, Wang Y, Zhu L, Li E.
    Sci Rep; 2015 Oct 07; 5():14744. PubMed ID: 26443483
    [Abstract] [Full Text] [Related]

  • 39. Serum Proteomic Analysis by Nanoflow LC-MS/MS-Based Proteomics in IgA Chronic Kidney Disease.
    Xue D, Li M, Xiang D, Sun J, Zhang W, Duan J, Cheng X, Wang C.
    Clin Lab; 2023 Mar 01; 69(3):. PubMed ID: 36912316
    [Abstract] [Full Text] [Related]

  • 40. Identification of mannose-binding lectin as a mechanism in progressive immunoglobulin A nephropathy.
    Shi B, Wang L, Mou S, Zhang M, Wang Q, Qi C, Cao L, Che X, Fang W, Gu L, Yan Y, Qian J, Ni Z.
    Int J Clin Exp Pathol; 2015 Mar 01; 8(2):1889-99. PubMed ID: 25973081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.